Results 121 to 130 of about 56,198 (306)

Giant Cell Tumors of the Synovial Sheaths (TCGGS) of the Hand: About 15 Cases

, 2023
M. Abakka, H. El Ouagari, M. J. Mekkaoui, M. Bouffetal, RA. Bassir, M. Kharmaze, MO Lamrani, MS. Berrada   +7 more
openalex   +1 more source

Liver Stiffness Characterization of OGTLKO Mouse Model of Progressive Liver Fibrosis

Journal of Ultrasound in Medicine, EarlyView.
Objectives O‐GlcNAcylation plays a key regulatory role in hepatic physiology, and its disruption leads to fibrosis in liver‐specific OGT knockout mice (OGTLKO), making this model valuable for studying advanced metabolic dysfunction‐associated steatohepatitis (MASH).
Gilles Renault, Lenin Chinchilla, Lourdes Massengo, Pierre Monbernard, Fadila Benhamed, Marion Regnier, Raphael Denis, Catherine Postic, Anthony Novell, Jean‐Luc Gennisson   +9 more
wiley   +1 more source

Granulomatous Panniculitis in a Patient Treated With Cemiplimab: Case Report and Literature Review

JEADV Clinical Practice, EarlyView.
ABSTRACT Immune checkpoint inhibitors (ICIs) have become a cornerstone in the treatment of advanced malignancies by enhancing antitumor immunity, but they may also trigger a broad spectrum of immune‐related adverse events (irAEs) involving multiple organs.
B. Lada‐Colunga, J. L. Artola‐Igarza, N. Martinez‐Peña, I. Arevalo‐Ortega, J. Rodriguez‐Blandon, G. Cancho‐Galan, R. Izu‐Belloso   +6 more
wiley   +1 more source

Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius [PDF]

Zhuoyu Li
openalex   +1 more source

Ultrastructure of two cases of anaplastic giant cell tumor of the human thyroid gland [PDF]

, 1975
J. M. Gaal, Éva Horváth, Kálmán Kovács   +2 more
openalex   +1 more source

Beyond PD‐1/PD‐L1: New Immune Checkpoints and Therapeutic Combinations in Cancer Immunotherapy

Medicine Bulletin, EarlyView.
ABSTRACT Recently, immune checkpoint inhibitors (ICIs), particularly PD‐1/PD‐L1 and CTLA‐4 inhibitors, have revolutionized cancer treatment, significantly improving survival rates for various malignancies. However, ICI therapies targeting single checkpoints on T cells still face numerous challenges, such as low response rates and post‐treatment ...
Yangyang Li, Zizhen Kang, Yanyun Du
wiley   +1 more source

Bilateral Simultaneous Primary Patellar Giant Cell Tumors. [PDF]

Indian J Orthop, 2023
Aydin F, Ogul H, Tuncer K, Kantarci M.
europepmc   +1 more source

Double central ray amputation of the third and fourth digits for recurrent giant cell tumors of the hand

, 2021
Muhammad Phetrus Johan, Dario Agustino Nelwan, Imeldy Prihatni Purnama, Ira Nong, Khrisna Yudha, Vicky William Paundanan   +5 more
openalex   +1 more source

Machine Learning for Predictive Modeling in Nanomedicine‐Based Cancer Drug Delivery

Med Research, EarlyView.
The integration of AI/ML into nanomedicine offers a transformative approach to therapeutic design and optimization. Unlike conventional empirical methods, AI/ML models (such as classification, regression, and neural networks) enable the analysis of complex clinical and formulation datasets to predict optimal nanoparticle characteristics and therapeutic
Rohan Chand Sahu, Sanchit Arora, Dinesh Kumar, Ashish Kumar Agrawal   +3 more
wiley   +1 more source

Open synovectomy for treatment of tenosynovial giant cell tumors of the knee in children. [PDF]

J Surg Case Rep
Georgiev H, Gecheva N, Gerchev A, Tserovski S, Nenov DN, Patrikov K.   +5 more
europepmc   +1 more source